CYD [CHINA YUCHAI INTERNATIONAL] 6-K: (Original Filing)

[China Yuchai International Announces Unaudited Second Quarter 2016 Financial Results SINGAPORE, Singapore – August 11, 2016 China Yuchai International Limited Financial highlights for the second quarter of 2016 • Revenue was RMB 3.7 billion (US$552.4 million) compared with RMB 4.1 billion in the second quarter of 2015; • Gross profit was RMB 710.4 million (US$107.1 million), a 19.4% gross margin] [CHINA YUCHAI INTERNATIONAL LIMITED UNAUDITED CONSOLIDATED STATEMENTS OF PROFIT OR LOSS For the quarters ended June 30, 2016 and 2015 (RMB and US$ amounts expressed in thousands, except per share data) June 30, 2016 June 30, 2015 RMB ’000 US$ ’000 RMB ’000 US$ ’000 Revenue 3,663,030 552,393 4,121,904 621,592 Cost of goods sold (2,952,611 ) (445,260 ) (3,284,735 )] [TABLE OF CONTENTS 99.1 Press Release date August 11, 2016 - China Yuchai International Announces Unaudited Second Quarter 2016 Financial Results 99.2 Unaudited Financial Statements for the Second Quarter Ended June 30, 2016 CHINA YUCHAI INTERNATIONAL LIMITED Weng Ming Hoh President and Director 6-K 1 d419651d6k.htm FORM 6-K]

By | 2016-08-12T02:04:59+00:00 August 11th, 2016|Categories: Chinese Stocks, CYD, SEC Original|Tags: , , , , , |0 Comments
Read More

CAAS [CHINA AUTOMOTIVE SYSTEMS] 10-Q: (Original Filing)

[] [RULE 13a-14(a) CERTIFICATION FOR FORM 10-Q I, Qizhou Wu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Automotive Systems, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [RULE 13a-14(a) CERTIFICATION FOR FORM 10-Q I, Jie Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Automotive Systems, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [18 U.S.C. SECTION 1350, OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Qizhou Wu Qizhou Wu President and Chief Executive Officer] [18 U.S.C. SECTION 1350, OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jie Li Jie Li Chief Financial Officer]

By | 2016-08-12T02:50:16+00:00 August 11th, 2016|Categories: CAAS, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

CYD [CHINA YUCHAI INTERNATIONAL] 6-K: China Yuchai International Announces Unaudited Second Quarter 2016

[China Yuchai International Announces Unaudited Second Quarter 2016 Financial Results SINGAPORE, Singapore – August 11, 2016 China Yuchai International Limited Financial highlights for the second quarter of 2016 • Revenue was RMB 3.7 billion (US$552.4 million) compared with RMB 4.1 billion in the second quarter of 2015; • Gross profit was RMB 710.4 million (US$107.1 million), a 19.4% gross margin] [CHINA YUCHAI INTERNATIONAL LIMITED UNAUDITED CONSOLIDATED STATEMENTS OF PROFIT OR LOSS For the quarters ended June 30, 2016 and 2015 (RMB and US$ amounts expressed in thousands, except per share data) June 30, 2016 June 30, 2015 RMB ’000 US$ ’000 RMB ’000 US$ ’000 Revenue 3,663,030 552,393 4,121,904 621,592 Cost of goods sold (2,952,611 ) (445,260 ) (3,284,735 )] [TABLE OF CONTENTS 99.1 Press Release date August 11, 2016 - China Yuchai International Announces Unaudited Second Quarter 2016 Financial Results 99.2 Unaudited Financial Statements for the Second Quarter Ended June 30, 2016 CHINA YUCHAI INTERNATIONAL LIMITED Weng Ming Hoh President and Director 6-K 1 d419651d6k.htm FORM 6-K]

By | 2016-08-12T02:05:50+00:00 August 11th, 2016|Categories: Chinese Stocks, CYD, Webplus ver|Tags: , , , , , |0 Comments
Read More

CAAS [CHINA AUTOMOTIVE SYSTEMS] 10-Q:

[] [RULE 13a-14(a) CERTIFICATION FOR FORM 10-Q I, Qizhou Wu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Automotive Systems, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [RULE 13a-14(a) CERTIFICATION FOR FORM 10-Q I, Jie Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Automotive Systems, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [18 U.S.C. SECTION 1350, OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Qizhou Wu Qizhou Wu President and Chief Executive Officer] [18 U.S.C. SECTION 1350, OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jie Li Jie Li Chief Financial Officer]

By | 2016-08-12T02:51:23+00:00 August 11th, 2016|Categories: CAAS, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

CPHI [CHINA PHARMA] 10-Q: (Original Filing)

[☐ Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer (Do not check if a smaller reporting company) ☒ Smaller reporting company ☐ ☒ APPLICABLE ONLY TO CORPORATE ISSUERS: 2 CHINA PHARMA HOLDINGS, INC. AND SUBSIDIARIES TABLE OF CONTENTS PART I FINANCIAL INFORMATION Page Item 1.] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 11, 2016 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 ex321.htm]

By | 2016-08-12T02:08:30+00:00 August 11th, 2016|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments
Read More

JD [JD.com] 6-K: (Original Filing)

[JD.com Announces Second Quarter 2016 Results Beijing, China Second Quarter 2016 Highlights · Net revenues 1 services and others · Gross profit Non-GAAP gross profit 2 · Loss from operations Non-GAAP income from operations 3 Non-GAAP operating margin of JD Mall 4 · Operating cash flow Free cash flow 5 6 (1) The U.S. dollar (US$) amounts disclosed in this] [001-36450 JD.com, Inc. 20th Floor, Building A, No. 18 Kechuang 11 Street Yizhuang Economic and Technological Development Zone Form 20-F x o o o JD.COM, INC. By :]

By | 2016-08-12T02:30:16+00:00 August 11th, 2016|Categories: Chinese Stocks, JD, SEC Original|Tags: , , , , , |0 Comments
Read More

HNP [HUANENG POWER INTERNATIONAL] 6-K: (Original Filing)

[This Form 6-K consists of: (a Sino-foreign joint stock limited company incorporated in the People’s Republic of China) (Stock Code: 902) ISSUE OF SHORT-TERM DEBENTURES Listing Rules Company As resolved at the 2014 annual general meeting of Huaneng Power International, Inc. (the “ Debentures The Company has recently completed the issue of the first tranche of the Company’s short-term debentures]

By | 2016-08-12T02:53:12+00:00 August 11th, 2016|Categories: Chinese Stocks, HNP, SEC Original|Tags: , , , , , |0 Comments
Read More

CPHI [CHINA PHARMA] 10-Q: ☐ Large accelerated filer ☐ Accelerated filer ☐

[☐ Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer (Do not check if a smaller reporting company) ☒ Smaller reporting company ☐ ☒ APPLICABLE ONLY TO CORPORATE ISSUERS: 2 CHINA PHARMA HOLDINGS, INC. AND SUBSIDIARIES TABLE OF CONTENTS PART I FINANCIAL INFORMATION Page Item 1.] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 11, 2016 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 ex321.htm]

By | 2016-08-12T02:09:18+00:00 August 11th, 2016|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments
Read More
Skip to toolbar